Human papillomavirus (HPV) replication occurs in terminally differentiating epithelium, and requires the activation of cellular DNA replication proteins. Unscheduled DNA replication can result in the induction of apoptosis, and the viral E6 protein induces the degradation of p53 to prevent this. It has recently been shown that HPV-18 E6 can also stimulate the degradation of Bak, a pro-apoptotic member of the Bcl-2 family. This report shows that the E6 proteins from HPV-18, HPV-16 and HPV-11 can all bind to Bak in vitro, stimulate its degradation in vivo and reduce Bak-induced apoptosis. However, the non-oncogenic HPV-11 E6 is less effective than the oncogenic E6 proteins in each of these assays, indicating that the ability of HPV to circumvent the apoptosis induced by Bak may contribute to the oncogenic potential of the virus.
BandaraL.,
AdamczewskiJ.,
HuntT.,
LaThangueN.1991; Cyclin A and the retinoblastoma gene product complex with a common transcription factor. Nature 352:249–251
BlantonR.,
ColtreraM.,
GownA.,
HalbertC.,
McDougallJ.1992; Expression of the HPV16 E7 gene generates proliferation in stratified squamous cell cultures which is independent of endogenous p53 levels. Cell Growth & Differentiation 3:791–802
ChellappanS.,
KrausV.,
KrogerB.,
MungerK.,
HowleyP.,
PhelpsW.,
NevinsJ.1992; Adenovirus E1A, simian virus 40 tumour antigen and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proceedings of the National Academy of Sciences, USA 89:4549–4553
ChengS.,
Schmidt-GrimmingerD.,
MurantT.,
BrokerT.,
ChowL.1995; Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes & Development 9:2335–2349
ChittendenT.,
FlemingtonC.,
HoughtonA.,
EbbR.,
GalloG.,
ElangovanB.,
ChinnaduraiG.,
LutzR.1995; A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO Journal 14:5589–5596
DoorbarJ.,
FooC.,
ColemanN.,
MedcalfL.,
HartleyO.,
ProsperoT.,
NapthineS.,
SterlingJ.,
WinterG.,
GriffinH.1997; Characterisation of events during the late stages of HPV-16 infection using high affinity synthetic FAbs to E4. Virology 238:40–52
DysonN.,
HowleyP.,
MungerK.,
HarlowE.1989; The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934–936
HuangD.,
CoryS.,
StrasserA.1997; Bcl-2, Bcl-XL and adenovirus protein E1B are functionally equivalent in their ability to inhibit cell death. Oncogene 14:405–414
HuibregtseJ.,
ScheffnerM.,
HowleyP.1991; A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO Journal 10:4129–4135
HuibregtseJ.,
ScheffnerM.,
HowleyP.1993; Localisation of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Molecular and Cellular Biology 13:4918–4927
KrajewskiS.,
KrajewskaM.,
ShabaikA.,
MiyashitaT.,
WangH.,
ReedJ.1994; Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. American Journal of Pathology 145:1323–1336
KrajewskiS.,
KrajewskaM.,
ReedJ.1996; Immunohistochemical analysis of in vivo patterns of Bak expression, a proapoptotic member of the Bcl-2 protein family. Cancer Research 56:2849–2855
MorrisJ.,
CrookT.,
BandaraL.,
DaviesR.,
LaThangueN.,
VousdenK.1993; Human papillomavirus type 16 E7 regulates E2F and contributes to mitogenic signalling. Oncogene 8:893–898
PaganoM.,
DurstM.,
JoswigS.,
DraettaG.,
Jansen-DürrP.1992; Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalised cells. Oncogene 7:1681–1686
PanH.,
GriepA.1995; Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development. Genes & Development 9:2157–2169
PhelpsW.,
BagchiS.,
BarnesJ.,
RaychaudhuriP.,
KrausV.,
MungerK.,
HowleyP.,
NevinsJ.1991; Analysis oftransactivation by human papillomavirus type 16 E7 and adenovirus 12S E1A suggests a common mechanism. Journal of Virology 65:6922–6930
ScheffnerM.,
WernessB.,
HuibregtseJ.,
LevineA.,
HowleyP.1990; The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129–1136